SQZ Biotechnologies Appoints Micah Zajic as Chief Financial Officer

Experienced Biotech Leader and Capital Markets Professional Elevated to Chief Financial Officer from Chief Business Officer Role Appointment Effective July 11, 2022 WATERTOWN, Mass.–(BUSINESS WIRE)–SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that it has appointed Micah Zajic, as the company’s Chief Financial Officer, … [Read more…]

Labcorp Forms Strategic Partnership With MD Anderson Cancer Center Foundation Spain to Increase Access to Early Phase Oncology Clinical Trials

BURLINGTON, N.C.–(BUSINESS WIRE)–Labcorp (NYSE: LH), a leading global life sciences company, today announced it has formed a strategic partnership with MD Anderson Cancer Center Foundation Spain, a non-profit organization whose objectives are to beat cancer and to increase accessibility of early phase oncology clinical trials. Through this collaboration, oncology clinical trials managed by Labcorp Drug … [Read more…]

Kezar Life Sciences Appoints Nick Mordwinkin as Chief Business Officer and Reports Updated Cash Position

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced the appointment of Nick Mordwinkin, Pharm.D., Ph.D., as Chief Business Officer. Dr. Mordwinkin will be key to the next stage of Kezar’s growth and will be responsible for shaping … [Read more…]

GSK prepares US for 2022-23 flu season with over 50 million influenza vaccine doses

GSK begins shipping FLULAVAL QUADRIVALENT and FLUARIX QUADRIVALENT PHILADELPHIA–(BUSINESS WIRE)–#Flu–GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its quadrivalent influenza vaccines to US healthcare providers and pharmacies in preparation for the 2022-23 season. This immediately follows a licensing and lot-release approval from the US Food and Drug Administration’s (FDA) Center for … [Read more…]

Omega Announces Second Quarter Earnings Release Date and Conference Call

HUNT VALLEY, Md.–(BUSINESS WIRE)–Omega Healthcare Investors, Inc. (NYSE:OHI) announced today that it is scheduled to release its earnings results for the quarter ended June 30, 2022, on Monday, August 1, 2022, after market close. In conjunction with its release, Omega will be conducting a conference call on Tuesday, August 2, 2022, at 10 a.m. Eastern … [Read more…]

Priority Health Expands Maternity Management Program to Additional Members

GRAND RAPIDS, Mich.–(BUSINESS WIRE)–Priority Health, a nationally recognized nonprofit health plan, has expanded its maternity management program, PriorityMOM™, to ASO, Medicaid and Individual members. PriorityMOM™ offers support to expectant mothers by walking alongside them through their pregnancy. The program helps reduce the total cost of maternity care, preterm births and postpartum readmissions. Since PriorityMOM™ launched … [Read more…]

Global Hospital EMR Systems Market (2022 to 2027) – Featuring Dr Chrono, eClinicalWorks, Epic Systems and GE Healthcare Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Hospital EMR Systems Market (2022-2027) by Component, Type, Deployment, Hospital Size, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Hospital EMR Systems Market is estimated to be USD 18.12 Bn in 2022 and is projected to reach USD 25.65 Bn … [Read more…]

The Worldwide Healthcare/Medical Simulation Industry is Projected to Reach $3.9 Billion by 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Healthcare / Medical Simulation Market (2022-2027) by Product & Service, End-User, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Healthcare / Medical Simulation Market is estimated to be USD 2.06 Bn in 2022 and is projected to reach USD 3.97 … [Read more…]

Global Melanoma Therapeutics Market (2022 to 2027) – Featuring AB Sciences, AbbVie and Genentech Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Melanoma Therapeutics Market (2022-2027) by Type of Melanoma, Therapy, Diagnostics, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Melanoma Therapeutics Market is estimated to be USD 12.06 Bn in 2022 and is projected to reach USD 19.79 Bn by 2027, … [Read more…]